{"id":485434,"date":"2020-05-20T07:28:02","date_gmt":"2020-05-20T07:28:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=485434"},"modified":"2020-05-20T07:28:02","modified_gmt":"2020-05-20T07:28:02","slug":"abilify-active-pharmaceutical-ingredients-api-insight-2020","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/abilify-active-pharmaceutical-ingredients-api-insight-2020_485434.html","title":{"rendered":"Abilify &#8211; Active Pharmaceutical ingredients &#8211;  API Insight, 2020"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1589894303.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Abilify - Active Pharmaceutical ingredients -  API Insight, 2020 \" src=\"https:\/\/www.abnewswire.com\/uploads\/1589894303.png\" alt=\"Abilify - Active Pharmaceutical ingredients -  API Insight, 2020 \" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Abilify &#8211; API Insight <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Abilify API Insight report includes Abilify overview, mechanism, regulatory milestones, deals &#038; partnerships, clinical trials and other development activities. It further provides Abilify&#8217;s patents information (US &#038; EU).<\/div>\n<p style=\"text-align: justify;\">&#8220;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/abilify-api-insights?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">Abilify &#8211; API Insight, 2020<\/a><\/strong>&#8221; report by DelveInsight provides product and API manufacturers details across US, Europe, China and India for Abilify.<\/p>\n<p style=\"text-align: justify;\">It includes Abilify overview, mechanism, regulatory milestones, deals &amp; partnerships, clinical trials and other development activities. It further provides Abilify&#8217;s patents information (US &amp; EU). It also features the historical and forecasted sales of Abilify till 2022. The report also highlights Abilify&#8217;s market competition and emerging therapies which are in the same space as Abilify.<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/abilify-api-insights?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">Click to know more.<\/a> <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report<\/li>\n<li>Patent information around Abilify in United States (US) and Europe (EU) has been highlighted<\/li>\n<li>API manufacturers for Abilify in United States, Europe, China and India<\/li>\n<li>The report contains historical and forecasted sales for Abilify till 2022<\/li>\n<li>Enlists the market competition and emerging therapies in the space where Abilify operates<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/abilify-api-insights?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">Request for sample pages.<\/a> <\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1.&nbsp;<\/strong>Report Introduction<\/p>\n<p style=\"text-align: justify;\"><strong>2.&nbsp;<\/strong>Abilify Overview<\/p>\n<ul style=\"text-align: justify;\">\n<li>Product Description<\/li>\n<li>Mechanism of Action<\/li>\n<li>Dosage and Administration<\/li>\n<li>Pharmacodynamic Properties<\/li>\n<li>Pharmacokinetic Properties<\/li>\n<li>Safety and Efficacy of Abilify<\/li>\n<li>Clinical Trial Description<\/li>\n<li>Adverse Reactions<\/li>\n<li>Product Development Activities<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>3.&nbsp;<\/strong>Product Details<\/p>\n<ul style=\"text-align: justify;\">\n<li>United States<\/li>\n<li>Europe<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>4.&nbsp;<\/strong>Abilify Global Sales Assessment<\/p>\n<ul style=\"text-align: justify;\">\n<li>Historical Global Sales<\/li>\n<li>Forecasted Global Sales<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>5.&nbsp;<\/strong>Patent Details<\/p>\n<p style=\"text-align: justify;\"><strong>6.&nbsp;<\/strong>Global API Manufacturers Assessment<\/p>\n<ul style=\"text-align: justify;\">\n<li>United States<\/li>\n<li>Europe<\/li>\n<li>China<\/li>\n<li>India<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>7.&nbsp;<\/strong>Market Competitors<\/p>\n<p style=\"text-align: justify;\"><strong>8.&nbsp;<\/strong>Emerging Therapies<\/p>\n<p style=\"text-align: justify;\"><strong>9.&nbsp;<\/strong>Appendix<\/p>\n<ul style=\"text-align: justify;\">\n<li>Methodology<\/li>\n<li>Consulting Services<\/li>\n<li>About DelveInsight<\/li>\n<li>Contact Us<\/li>\n<li>Disclaimer<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=pr&amp;utm_medium=jewish&amp;utm_campaign=vinita\"><strong>DelveInsight<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.<\/p>\n<p style=\"text-align: justify;\">Browse through our vast repository from <a rel=\"nofollow\" href=\"https:\/\/delveinsight.com\/report-store.php?utm_source=pr&amp;utm_medium=jewish&amp;utm_campaign=vinita\">here<\/a>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57049.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Vinita Rakheja <br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=abilify-active-pharmaceutical-ingredients-api-insight-2020\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=abilify-active-pharmaceutical-ingredients-api-insight-2020\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abilify &#8211; API Insight The Abilify API Insight report includes Abilify overview, mechanism, regulatory milestones, deals &#038; partnerships, clinical trials and other development activities. It further provides Abilify&#8217;s patents information (US &#038; EU). &#8220;Abilify &#8211; API Insight, 2020&#8221; report by &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/abilify-active-pharmaceutical-ingredients-api-insight-2020_485434.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,413,404],"tags":[],"class_list":["post-485434","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Services","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/485434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=485434"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/485434\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=485434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=485434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=485434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}